Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ADAM17 |
| Upstream (Parents) |
|---|
| (<<) CASP9 → ADAM17 |
| (<<) CAT → ADAM17 |
| (<<) DEAF1 → ADAM17 |
| (<<) ELF2 → ADAM17 |
| (<<) GNA11 → ADAM17 |
| (<<) MAT2A → ADAM17 |
| (<<) MPP1 → ADAM17 |
| (<<) PRKAB1 → ADAM17 |
| (<<) RASSF1 → ADAM17 |
| (<<) RPL26L1 → ADAM17 |
| (<<) SH3GLB1 → ADAM17 |
| (<<) STK16 → ADAM17 |
| (<<) TINF2 → ADAM17 |
| (<<) TMC7 → ADAM17 |
| (<<) YWHAE → ADAM17 |
| (<<) YWHAQ → ADAM17 |
| Downstream (Children) |
|---|
| ADAM17 → BCL3 (>>) |
| ADAM17 → CCL24 (>>) |
| ADAM17 → EML4 (>>) |
| ADAM17 → GRPEL1 (>>) |
| ADAM17 → HMGCS1 (>>) |
| ADAM17 → LOC441204 (>>) |
| ADAM17 → YRDC (>>) |
